Cytochrome P-450 CYP3A Inhibitors
"Cytochrome P-450 CYP3A Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.
Descriptor ID |
D065692
|
MeSH Number(s) |
D27.505.389.500.503 D27.505.519.389.335.503
|
Concept/Terms |
Cytochrome P-450 CYP3A Inhibitors- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P 450 CYP3A Inhibitors
- CYP3A Inhibitors
- Inhibitors, CYP3A
- P450 CYP3A Inhibitors
- Inhibitors, P450 CYP3A
Cytochrome P-450 CYP3A7 Inhibitors- Cytochrome P-450 CYP3A7 Inhibitors
- Cytochrome P 450 CYP3A7 Inhibitors
- P450 CYP3A7 Inhibitors
- CYP3A7 Inhibitors, P450
- Inhibitors, P450 CYP3A7
- CYP3A7 Inhibitors
- Inhibitors, CYP3A7
Cytochrome P-450 CYP3A5 Inhibitors- Cytochrome P-450 CYP3A5 Inhibitors
- Cytochrome P 450 CYP3A5 Inhibitors
- P450 CYP3A5 Inhibitors
- CYP3A5 Inhibitors, P450
- CYP3A5 Inhibitors
- Inhibitors, CYP3A5
Cytochrome P-450 CYP3A4 Inhibitors- Cytochrome P-450 CYP3A4 Inhibitors
- Cytochrome P 450 CYP3A4 Inhibitors
- P450 CYP3A4 Inhibitors
- Inhibitors, P450 CYP3A4
- CYP3A4 Inhibitors
- Inhibitors, CYP3A4
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP3A Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP3A Inhibitors".
This graph shows the total number of publications written about "Cytochrome P-450 CYP3A Inhibitors" by people in this website by year, and whether "Cytochrome P-450 CYP3A Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2014 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytochrome P-450 CYP3A Inhibitors" by people in Profiles.
-
Feld JJ, Jacobson IM, Jensen DM, Foster GR, Pol S, Tam E, Jablkowski M, Berak H, Vierling JM, Yoshida EM, Perez-Gomez HR, Scalori A, Hooper GJ, Tavel JA, Navarro MT, Shahdad S, Kulkarni R, Le Pogam S, Nájera I, Eng S, Lim CY, Shulman NS, Yetzer ES. Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin. J Hepatol. 2015 Feb; 62(2):294-302.
-
Zhang X, Galinsky RE, Kimura RE, Quinney SK, Jones DR, Hall SD. Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metab Dispos. 2010 Jan; 38(1):61-72.
-
Quinney SK, Galinsky RE, Jiyamapa-Serna VA, Chen Y, Hamman MA, Hall SD, Kimura RE. Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats. Drug Metab Dispos. 2008 Jun; 36(6):1097-101.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|